Eli Lilly and Company (LLY) Financials

LLY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 64.0 billion 53.1 billion
2023-09-30 57.9 billion 46.6 billion
2023-06-30 54.8 billion 43.7 billion
2023-03-31 53.2 billion 41.9 billion

LLY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -2.0 billion 120.2 million
2023-09-30 -1.8 billion 215.6 million
2023-06-30 -204.4 million 161.5 million
2023-03-31 827.1 million 131.2 million

LLY Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 2.2 billion
2023-09-30 -57.4 million
2023-06-30 1.8 billion
2023-03-31 1.3 billion

LLY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 2.9 billion - -
2023-09-30 2.5 billion 17.9 billion -
2023-06-30 2.8 billion 18.2 billion -
2023-03-31 3.7 billion 18.9 billion -

LLY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 904.0 million
2023-09-30 899.8 million
2023-06-30 902.7 million
2023-03-31 903.3 million

LLY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.7 billion 2.6 billion 1.5 billion 461.9 million
2023-09-30 4.0 billion 2.4 billion 1.8 billion -
2023-06-30 836.3 million 2.4 billion 1.9 billion -
2023-03-31 903.5 million 2.0 billion 1.7 billion -

LLY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 9.4 billion 1.7 billion
2023-09-30 9.5 billion 1.9 billion
2023-06-30 8.3 billion 1.8 billion
2023-03-31 7.0 billion 1.6 billion

LLY

List: Contenders

Price: $726.31

52 week price:
367.35
800.78

Dividend Yield: 0.01%

5-year range yield:
0.01%
2.92%

Forward Dividend Yield: 0.72%

Payout Ratio: 93.69%

Payout Ratio Range:
35.56%
469.70%

Dividend Per Share: 5.20 USD

Earnings Per Share: 5.79 USD

P/E Ratio: 133.87

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 2.6 million

Ebitda: 758.9 million

Market Capitalization: 714.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 53

DGR3: 15.02%

DGR5: 13.93%

DGR10: 7.77%

DGR20: 6.15%

Links: